Siena, Italy and Nottingham, UK – Exosomics SpA, the leading extracellular vesicles biotech company, today announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide. In this strategic partnership, Exosomics becomes NanoFCM’s approved service supplier of nano-flow cytometry measurements. These can be performed as stand-alone or […]
SAN FRANCISCO, CA – MGI, one of the world’s leading manufacturers of DNA sequencing instruments, today launched its One Million Genomes Total Solution, a full-process software and hardware solution for one million genome projects. The integrated system will promote standardization and effectively solve the pain points in the industry and accelerate the arrival of the […]
CAMBRIDGE, UK, and LEUVEN, Belgium – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive collaboration agreement to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. As the understanding of genomic drivers of cancer evolves, NGS has […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that further the company’s commitment to unlocking the power of the genome. The NextSeq 2000 Sequencing System — The latest NGS system from Illumina […]
First Company Developing a KRAS(G12C) Inhibitor to Announce Multi-Platform Companion Diagnostics Collaborations With Guardant Health and QIAGEN Will Develop Blood- and Tissue-Based Companion Diagnostics For Investigational KRAS(G12C) Inhibitor AMG 510 KRAS G12C is Present in 13% of Non-Small Cell Lung Cancers With no Approved Targeted Treatments THOUSAND OAKS, Calif. — Amgen (NASDAQ: AMGN) today announced […]
MGI makes the following statement in response to Illumina’s patent litigation in the UK and Sweden: We believe these claims have no merit and are typical Illumina tactics intended to maintain a monopolistic market position and prevent choice from being offered to customers. We intend to vigorously defend ourselves, as we have in other jurisdictions. […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed two additional patent infringement suits relating to BGI’s sequencing products, including the DNBSeq-400 (also known as MGISeq-2000), DNBSeq-T7, and related chemistry reagents. The first complaint was filed against MGI Tech Co., Ltd. and Latvia MGI Tech SIA in the High Court of […]
Vienna, Austria – The massive output of modern short-read next generation sequencing (NGS) platforms allows to multiplex hundreds of samples to be processed in one NGS run. Each sample is identified by adding a unique index sequence to an NGS library, ensuring these libraries can be mixed and sequenced collectively. This system reduces sequencing costs […]
Co-marketing partnership to drive awareness of ArcherDX IVD products and increase access to vital genomic information in the community oncology care setting Boulder, Colorado – ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ILMN) intended to broaden access of next generation sequencing (NGS)-based oncology testing, including companion diagnostics for therapeutic selection, personalized […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
